Human Fatty Liver Disease: Old Questions and New Insights

Cohen, Jonathan C., Horton, Jay D., Hobbs, Helen H.·2011·Science

DOI 10.1126/science.1204265

Cited by (1,009)

Items 101–200 of 1,009

The beneficial effects of Mediterranean diet over low-fat diet may be mediated by decreasing hepatic fat content
Gepner, Yftach, Shelef, Ilan, Komy, Oded, Cohen, Noa, Schwarzfuchs, Dan, Bril, Nitzan, Rein, Michal, Serfaty, Dana, Kenigsbuch, Shira, Zelicha, Hila et al. · 2019 · Journal of Hepatology
Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment
Paola Dongiovanni, Quentin Mark Anstee, Luca V. C. Valenti · 2013 · Current Pharmaceutical Design
Bi-directional analysis between fatty liver and cardiovascular disease risk factors
Jiantao Ma, Shih‐Jen Hwang, Alison Pedley, Joseph M. Massaro, Udo Hoffmann, Raymond T. Chung, Emelia J. Benjamin, Daniel A Levy, Caroline S. Fox, Michelle T. Long · 2016 · Journal of Hepatology
Obesity and aging: Molecular mechanisms and therapeutic approaches
Ana L. Santos, Sanchari Sinha · 2021 · Ageing Research Reviews
Obesity and cancer pathogenesis
Nathan A. Berger · 2014 · Annals of the New York Academy of Sciences
Inactivation of Tm6sf2, a gene defective in fatty liver disease, impairs lipidation but not secretion of very low density lipoproteins
Smagris, Eriks, Gilyard, Shenise, BasuRay, Soumik, Cohen, Jonathan C., Hobbs, Helen H. · 2016 · Journal of Biological Chemistry
Susceptibility of Nrf2-Null Mice to Steatohepatitis and Cirrhosis upon Consumption of a High-Fat Diet Is Associated with Oxidative Stress, Perturbation of the Unfolded Protein Response, and Disturbance in the Expression of Metabolic Enzymes but Not with Insulin Resistance
Paul J. Meakin, Sudhir Chowdhry, Ritu S. Sharma, Fiona B. Ashford, Shaun V Walsh, Rory J. McCrimmon, Albena T. Dinkova‐Kostova, John Francis Dillon, John D. Hayes, Michael L.J. Ashford · 2014 · Molecular and Cellular Biology
Fatty Acid–Regulated Transcription Factors in the Liver
Donald Β. Jump, Sasmita Tripathy, Christopher M. Depner · 2013 · Annual Review of Nutrition
Mechanisms of lysophosphatidylcholine-induced hepatocyte lipoapoptosis
Kakisaka, Keisuke, Cazanave, Sophie C., Fingas, Christian D., Guicciardi, Maria E., Bronk, Steven F., Werneburg, Nathan W., Mott, Justin L., Gores, Gregory J. · 2012 · American Journal of Physiology-Gastrointestinal and Liver Physiology
Improved Glycaemia Correlates with Liver Fat Reduction in Obese, Type 2 Diabetes, Patients Given Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists
Cuthbertson, Daniel J., Irwin, Andrew, Gardner, Chris J., Daousi, Christina, Purewal, Tej, Furlong, Niall, Goenka, Niru, Thomas, E. Louise, Adams, Valerie L., Pushpakom, Sudeep P. et al. · 2012 · PLoS ONE
Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population
Rennan Feng, Shanshan Du, Cheng Wang, Yanchuan Li, Liyan Liu, Fuchuan Guo, Changhao Sun · 2014 · World Journal of Gastroenterology
Obesity-Dependent Metabolic Signatures Associated with Nonalcoholic Fatty Liver Disease Progression
J. Barr, Juan Caballería, Ibon Martínez‐Arranz, Agustín Domínguez‐Díez, Cristina Alonso, Jordi Muntané, Miriam Pérez-Cormenzana, Carmelo García‐Monzón, Rebeca Mayo, Antonio Martín‐Duce et al. · 2012 · Journal of Proteome Research
Comparative proteomic study reveals 17β-HSD13 as a pathogenic protein in nonalcoholic fatty liver disease
Wen Su, Yang Wang, Xiao Jia, Wenhan Wu, Linghai Li, Xiaodong Tian, Sha Li, Chunjiong Wang, Hua-Min Xu, Jiaqi Cao et al. · 2014 · Proceedings of the National Academy of Sciences
Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease
Srinevas K. Reddy, Jennifer Lynne Steel, Hui‐Wei Chen, David J. DeMateo, Jon S. Cardinal, Jaideep Behari, Abhinav Humar, Wallis J. Marsh, David A. Geller, Allan Tsung · 2011 · Hepatology
CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis
Xiang Zhang, Jiayun Shen, Kwan Man, Eagle SH Chu, Tung On Yau, Joanne C.Y. Sung, Minnie Y.Y. Go, Jun Deng, Liwei Lu, Vincent Wai‐Sun Wong et al. · 2014 · Journal of Hepatology
Pathogenesis of nonalcoholic steatohepatitis
Wensheng Liu, Robert D. Baker, Tavleen Bhatia, Lixin Zhu, Susan S. Baker · 2016 · Cellular and Molecular Life Sciences
Cysteamine: an old drug with new potential
Martine T. P. Besouw, Rosalinde Masereeuw, Lambert van den Heuvel, Elena N. Levtchenko · 2013 · Drug Discovery Today
Perfluoroalkyl substances and severity of nonalcoholic fatty liver in Children: An untargeted metabolomics approach
Ran Jin, Rob McConnell, Catherine E. Cioffi, Shujing Xu, Douglas Ian Walker, Nikos Stratakis, Dean P. Jones, Gary Wright Miller, Cheng Peng, David V. Conti et al. · 2019 · Environment International
Lipid-mediated regulation of SKN-1/Nrf in response to germ cell absence
Michael J. Steinbaugh, Sri Devi Narasimhan, Stacey Robida-Stubbs, Lorenza E Moronetti Mazzeo, Jonathan M. Dreyfuss, John M Hourihan, Prashant Raghavan, Theresa N. Operaña, Reza Esmaillie, T. Keith Blackwell · 2015 · eLife
Ursolic Acid Increases Skeletal Muscle and Brown Fat and Decreases Diet-Induced Obesity, Glucose Intolerance and Fatty Liver Disease
Steven D. Kunkel, Christopher Elmore, Kale S. Bongers, Scott Matthew Ebert, Daniel K. Fox, Michael C. Dyle, Steven A. Bullard, Christopher M. Adams · 2012 · PLoS ONE
Is Liver Enzyme Release Really Associated with Cell Necrosis Induced by Oxidant Stress?
Martha Lucinda Contreras-Zentella, Rolando Efraín Hernández-Muñoz · 2015 · Oxidative Medicine and Cellular Longevity
AMPK Re-Activation Suppresses Hepatic Steatosis but its Downregulation Does Not Promote Fatty Liver Development
Nadia Boudaba, Allison Marion, Camille Huet, Rémi Pierre, Benoı̂t Viollet, Marc Foretz · 2018 · EBioMedicine
Body mass index in school-aged children and the risk of routinely diagnosed non-alcoholic fatty liver disease in adulthood: a prospective study based on the Copenhagen School Health Records Register
Esther Zimmermann, Michael Gamborg, Claus Holst, Jennifer L. Baker, Thorkild I A Sørensen, Tina Landsvig Berentzen · 2015 · BMJ Open
Sugar-sweetened beverage, diet soda, and fatty liver disease in the Framingham Heart Study cohorts
Jiantao Ma, Caroline S. Fox, Paul F. Jacques, Elizabeth K. Speliotes, Udo Hoffmann, Caren E. Smith, Edward J. Saltzman, Nicola Mary McKeown · 2015 · Journal of Hepatology
Targeting nuclear receptors for the treatment of fatty liver disease
Naoki Tanaka, Toshifumi Aoyama, Shioko Kimura, Frank J. Gonzalez · 2017 · Pharmacology & Therapeutics
Intestinal Barrier and Permeability in Health, Obesity and NAFLD
Piero Portincasa, Leonilde Bonfrate, Mohamad Khalil, Maria De Angelis, Francesco Maria Calabrese, Mauro D’Amato, David Q.‐H. Wang, Agostino Di Ciaula · 2021 · Biomedicines
The Problem of Establishing Relationships between Hepatic Steatosis and Hepatic Insulin Resistance
Robert V. Farese, Rudolf Zechner, Christopher B. Newgard, Tobias C. Walther · 2012 · Cell Metabolism
Low Circulating Adropin Concentrations with Obesity and Aging Correlate with Risk Factors for Metabolic Disease and Increase after Gastric Bypass Surgery in Humans
Andrew A. Butler, Charmaine S. Tam, Kimber L. Stanhope, Bruce M. Wolfe, Mohamed R. Ali, Majella M O'Keeffe, Marie‐Pierre St‐Onge, Éric Ravussin, Peter Joseph Havel · 2012 · The Journal of Clinical Endocrinology & Metabolism
TREM2 in the pathogenesis of AD: a lipid metabolism regulator and potential metabolic therapeutic target
Li, Rui-Yang, Qin, Qi, Yang, Han-Chen, Wang, Ying-Ying, Mi, Ying-Xin, Yin, Yun-Si, Wang, Meng, Yu, Chao-Ji, Tang, Yi · 2022 · Molecular Neurodegeneration
Ketogenesis prevents diet-induced fatty liver injury and hyperglycemia
David G. Cotter, Barış Erçal, Xiaojing Huang, Jamison M. Leid, D. André d’Avignon, Mark J. Graham, Dennis J. Dietzen, Elizabeth M. Brunt, Gary J. Patti, Peter A. Crawford · 2014 · Journal of Clinical Investigation
Farnesoid X receptor: a master regulator of hepatic triglyceride and glucose homeostasis
Yang Jiao, Yan Lu, Xiao-ying Li · 2014 · Acta Pharmacologica Sinica
Controlling the size of lipid droplets: lipid and protein factors
Hongyuan Yang, Anne M. Galea, Vladimir Sytnyk, Merlin Crossley · 2012 · Current Opinion in Cell Biology
Hepatic NAD+ deficiency as a therapeutic target for non‐alcoholic fatty liver disease in ageing
Cancan Zhou, Xi Yang, Xia Hua, Jian Liu, Mao-bing Fan, Guoqiang Li, Jie Song, Tian‐Ying Xu, Zhiyong Li, Yun‐Feng Guan et al. · 2016 · British Journal of Pharmacology
Organellar proteomics and phospho-proteomics reveal subcellular reorganization in diet-induced hepatic steatosis
Krahmer, Natalie, Najafi, Bahar, Schueder, Florian, Quagliarini, Fabiana, Steger, Martin, Seitz, Susanne, Kasper, Robert, Salinas, Favio, Cox, Jürgen, Uhlenhaut, Nina Henriette et al. · 2018 · Developmental Cell
Impact of different ectopic fat depots on cardiovascular and metabolic diseases
Ferrara, Daniele, Montecucco, Fabrizio, Dallegri, Franco, Carbone, Federico · 2019 · Journal of Cellular Physiology
Fecal microbiota transplantation confers beneficial metabolic effects of diet and exercise on diet-induced obese mice
Zi-Lun Lai, Ching-Hung Tseng, Hsiu J. Ho, Cynthia Cheung, Jian-Yong Lin, Yi–Ju Chen, Fu-Chou Cheng, Yao‐Chun Hsu, Jaw‐Town Lin, Emad M. El-Omar et al. · 2018 · Scientific Reports
Organoid models of gastrointestinal cancers in basic and translational research
Harry Cheuk-Hay Lau, Onno Kranenburg, Haipeng Xiao, Jun Yu · 2020 · Nature Reviews Gastroenterology & Hepatology
Elovl6 promotes nonalcoholic steatohepatitis
Takashi Matsuzaka, Ayaka Atsumi, Rie Matsumori, Tang Nie, Haruna Shinozaki, Noriko Suzuki‐Kemuriyama, Motoko Kuba, Yoshimi Nakagawa, Kiyo‐aki Ishii, Masako Shimada et al. · 2012 · Hepatology
The triglyceride synthesis enzymes DGAT1 and DGAT2 have distinct and overlapping functions in adipocytes
Chitraju, Chandramohan, Walther, Tobias C., Farese, Robert V. · 2019 · Journal of Lipid Research
Hepatic lipid droplet homeostasis and fatty liver disease
Fabian Seebacher, Anja Zeigerer, Nora Kory, Natalie Krahmer · 2020 · Seminars in Cell and Developmental Biology
Endoplasmic reticulum stress induces hepatic steatosis via increased expression of the hepatic very low-density lipoprotein receptor
Hyunsun Jo, Sung Sik Choe, Kyung Cheul Shin, Hagoon Jang, Jae‐Ho Lee, Je Kyung Seong, Sung Hoon Back, Jae Bum Kim · 2012 · Hepatology
Nonalcoholic fatty liver disease: A comprehensive review of a growing epidemic
Kareem Hassan · 2014 · World Journal of Gastroenterology
Mitochondrial metabolic dysfunction and non-alcoholic fatty liver disease: new insights from pathogenic mechanisms to clinically targeted therapy
Youwei Zheng, Shiting Wang, Jialiang Wu, Yong Wang · 2023 · Journal of Translational Medicine
Lipid droplet proteins and metabolic diseases
Shimeng Xu, Xuelin Zhang, Pingsheng Liu · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Pathogenesis of NASH: how metabolic complications of overnutrition favour lipotoxicity and pro-inflammatory fatty liver disease
Farrell, Geoffrey C., Haczeyni, Fahrettin, Chitturi, Shivakumar · 2018 · Advances in Experimental Medicine and Biology
Role of SREBPs in Liver Diseases: A Mini-review
Azam Moslehi, Zeinab Hamidizad · 2018 · Journal of Clinical and Translational Hepatology
Lipoprotein Metabolism, Dyslipidemia, and Nonalcoholic Fatty Liver Disease
Edward A A Fisher, David E. Cohen · 2013 · Seminars in Liver Disease
Estrogen Signals Through Peroxisome Proliferator-Activated Receptor−γ Coactivator 1α to Reduce Oxidative Damage Associated With Diet-Induced Fatty Liver Disease
Aurèle Besse‐Patin, Mélissa Léveillé, Daniel Oropeza, Bich Nguyen, Annik Prat, Jennifer L. Estall · 2016 · Gastroenterology
Non-alcoholic fatty liver disease in 2015
Monjur Ahmed∥ · 2015 · World Journal of Hepatology
Canagliflozin, an SGLT2 inhibitor, attenuates the development of hepatocellular carcinoma in a mouse model of human NASH
Kumiko Shiba, Kyoichiro Tsuchiya, Chikara Komiya, Yasutaka Miyachi, Kentaro Mori, Noriko Shimazu, Shinobu Yamaguchi, Naomi Ogasawara, Makoto Katoh, Michiko Itoh et al. · 2018 · Scientific Reports
Liver governs adipose remodelling via extracellular vesicles in response to lipid overload
Yue Zhao, Mengfei Zhao, Shan Jiang, Jing Wu, Jia Liu, Xianwen Yuan, Di Shen, Jingzi Zhang, Nan Zhou, Jian He et al. · 2020 · Nature Communications
Kupffer Cell Metabolism and Function.
Anh Thu Nguyen‐Lefebvre, Anatolij Horuzsko · 2015 · PubMed
Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic Steatohepatitis
Chongshu Jian, Jiajun Fu, Xu Cheng, Lijun Shen, Yan‐Xiao Ji, Xiaoming Wang, Shan Pan, Han Tian, Song Tian, Rufang Liao et al. · 2020 · Cell Metabolism
Of mice and men: The physiological role of adipose triglyceride lipase (ATGL)
Renate Schreiber, Hao Xie, Martina Schweiger · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Increased risk of cardiovascular disease and chronic kidney disease in NAFLD
E. Bonora, G. Targher · 2012 · Nature Reviews Gastroenterology &Hepatology
Vitamin D And Nonalcoholic Fatty Liver Disease (Nafld): Is It More Than Just An Association?
Ryan M. Kwok, Dawn McDowell Torres, Stephen A. Harrison · 2013 · Hepatology
Hepatic neuregulin 4 signaling defines an endocrine checkpoint for steatosis-to-NASH progression
Liang Guo, Peng Zhang, Zhimin Chen, Houjun Xia, Siming Li, Yanqiao Zhang, Sune Kobberup, Weiping Zou, Jiandie D. Lin · 2017 · Journal of Clinical Investigation
Function, Detection and Alteration of Acylcarnitine Metabolism in Hepatocellular Carcinoma
Shangfu Li, Dan Gao, Yuyang Jiang · 2019 · Metabolites
External validation of the fatty liver index and lipid accumulation product indices, using 1H-magnetic resonance spectroscopy, to identify hepatic steatosis in healthy controls and obese, insulin-resistant individuals
Daniel James Cuthbertson, Martin O. Weickert, Daniel T. Lythgoe, Victoria S. Sprung, Rebecca Dobson, Fariba Shoajee-Moradie, Anne Margot Umpleby, Andreas F. H. Pfeiffer, Elizabeth Louise Thomas, Jimmy David Bell et al. · 2014 · European Journal of Endocrinology
Sirtuin-6–Dependent Genetic And Epigenetic Alterations Are Associated With Poor Clinical Outcome in Hepatocellular Carcinoma Patients
Jens Uwe Marquardt, Kerstin Fischer, Katharina Baus, Anubha Kashyap, Shengyun Ma, Markus Krupp, Matthias Linke, Andreas Teufel, Ulrich Zechner, Dennis J. Strand et al. · 2013 · Hepatology
Non-alcoholic fatty liver disease and progression of coronary artery calcium score: a retrospective cohort study
Dong Hyun Sinn, Danbee Kang, Yoosoo Chang, Seungho Ryu, Seonhye Gu, Hyun‐Kyoung Kim, Donghyeong Seong, Soo Jin Cho, Byoung-Kee Yi, Hyung‐Doo Park et al. · 2016 · Gut
Insights into the Epidemiology, Pathogenesis, and Therapeutics of Nonalcoholic Fatty Liver Diseases
Yao Yu, Jingjing Cai, Zhi‐Gang She, Hongliang Li · 2018 · Advanced Science
Hepatic Diacylglycerol-Associated Protein Kinase Cε Translocation Links Hepatic Steatosis to Hepatic Insulin Resistance in Humans
Kasper W. ter Horst, Pim W. Gilijamse, Ruth I. Versteeg, Mariëtte T. Ackermans, Aart Johannes Nederveen, Susanne Eva la Fleur, Johannes Anthonius Romijn, Max Nieuwdorp, Dongyan Zhang, Varman T. Samuel et al. · 2017 · Cell Reports
Long noncoding RNA licensing of obesity-linked hepatic lipogenesis and NAFLD pathogenesis
Xu-Yun Zhao, Xuelian Xiong, Tongyu Liu, Lin Mi, Xiaoling Peng, Crystal Rui, Liang Guo, Siming Li, Xiaoying Li, Jiandie D. Lin · 2018 · Nature Communications
Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Yoshihisa Takahashi · 2015 · World Journal of Gastroenterology
Mitochondrial Dysfunction: A Basic Mechanism in Inflammation-Related Non-Communicable Diseases and Therapeutic Opportunities
Anna Hernández‐Aguilera, Anna Rull, Esther Rodríguez‐Gallego, Marta Riera-Borrull, Fedra Luciano‐Mateo, Jordi Camps, Javier Abel Menéndez, Jorge Joven · 2013 · Mediators of Inflammation
High folic acid consumption leads to pseudo-MTHFR deficiency, altered lipid metabolism, and liver injury in mice
Karen E. Christensen, Leonie G. Mikael, Kit‐Yi Leung, Nancy Lévesque, Li-Yuan Deng, Qing Hua Wu, Olga Malysheva, Ana F. Best, Marie A. Caudill, Nicholas D. E. Greene et al. · 2015 · American Journal of Clinical Nutrition
Fatty acids promote fatty liver disease via the dysregulation of 3-mercaptopyruvate sulfurtransferase/hydrogen sulfide pathway
Meng Li, Chengfu Xu, Junping Shi, Jiexia Ding, Xingyong Wan, Dahua Chen, Jianguo Gao, Chunxiao Li, Jie Zhang, Yiming Lin et al. · 2017 · Gut
ACSS2 promotes systemic fat storage and utilization through selective regulation of genes involved in lipid metabolism
Zhi‐Guang Huang, Menglu Zhang, Abigail A. Plec, Sandi Jo Estill, Ling Cai, Joyce J. Repa, Steven Lanier McKnight, Benjamin P. Tu · 2018 · Proceedings of the National Academy of Sciences
The ABCG2 Q141K hyperuricemia and gout associated variant illuminates the physiology of human urate excretion
Kazi Mirajul Hoque, Eryn E. Dixon, Raychel M. Lewis, Jordyn Allan, Greg D. Gamble, Amanda J. Phipps‐Green, Victoria L. Halperin Kuhns, Anne M. Horne, Lisa K. Stamp, Tony Raymond Merriman et al. · 2020 · Nature Communications
Effects of Ferulic Acid and γ-Oryzanol on High-Fat and High-Fructose Diet-Induced Metabolic Syndrome in Rats
Ou Wang, Jia Liu, Qian Cheng, Xiaoxuan Guo, Yong Wang, Liang Zhao, Feng Li Zhou, Baoping Ji · 2015 · PLoS ONE
Nonalcoholic fatty liver disease: A main driver of insulin resistance or a dangerous liaison?
Nanda Gruben, Ronit Shiri‐Sverdlov, Debby P.Y. Koonen, Marten H. Hofker · 2014 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Berberine attenuates hepatic steatosis and enhances energy expenditure in mice by inducing autophagy and fibroblast growth factor 21
Yixuan Sun, Mingfeng Xia, Hongmei Yan, Yamei Han, Feifei Zhang, Zhimin Hu, Aoyuan Cui, Fengguang Ma, Zhengshuai Liu, Qi Gong et al. · 2017 · British Journal of Pharmacology
Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis
Paola Dongiovanni, Stefano Romeo, Luca V. C. Valenti · 2015 · BioMed Research International
Tmbim1 is a multivesicular body regulator that protects against non-alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4
Guang‐Nian Zhao, Peng Zhang, Jun Gong, Xiao‐Jing Zhang, Pi‐Xiao Wang, Miao Yin, Zhou Jiang, Lijun Shen, Yan‐Xiao Ji, Jingjing Tong et al. · 2017 · Nature Medicine
Quercetin ameliorates HFD-induced NAFLD by promoting hepatic VLDL assembly and lipophagy via the IRE1a/XBP1s pathway
Xinhong Zhu, Ting Xiong, Peiyi Liu, Xiaoping Guo, Lin Xiao, Feng Zhou, Yuhan Tang, Ping Yao · 2018 · Food and Chemical Toxicology
TM6SF2: A Novel Genetic Player in Nonalcoholic Fatty Liver and Cardiovascular Disease
Fei Luo, Federico Oldoni, Avash Das · 2021 · Hepatology Communications
Docosahexaenoic Acid Attenuates Hepatic Inflammation, Oxidative Stress, and Fibrosis without Decreasing Hepatosteatosis in a Ldlr Mouse Model of Western Diet-Induced Nonalcoholic Steatohepatitis
Christopher M. Depner, Kenneth A. Philbrick, Donald Β. Jump · 2013 · Journal of Nutrition
Lipid Metabolism in Metabolic-Associated Steatotic Liver Disease (MASLD)
Majid Mufaqam Syed‐Abdul · 2023 · Metabolites
Coumarin-Based Fluorescent Probes for Super-resolution and Dynamic Tracking of Lipid Droplets
Hongkang Xu, Huihui Zhang, Gang Liu, Lin Kong, Xiaojiao Zhu, Xiaohe Tian, Zhongping Zhang, Ruilong Zhang, Zhichao Wu, Yupeng Tian et al. · 2018 · Analytical Chemistry
Metabolic Targets in Nonalcoholic Fatty Liver Disease
William P. Esler, Kendra K. Bence · 2019 · Cellular and Molecular Gastroenterology and Hepatology
Innate immune activation in obesity
Carey Nien-Kai Lumeng · 2012 · Molecular Aspects of Medicine
Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease
Jump, Donald B., Lytle, Kelli A., Depner, Christopher M., Tripathy, Sasmita · 2018 · Pharmacology & Therapeutics
A monocarboxylate transporter required for hepatocyte secretion of ketone bodies during fasting
Sarah E. Hugo, Lourdes Cruz-Garcia, Santhosh Karanth, Ryan M. Anderson, Didier Y. R. Stainier, Amnon Schlegel · 2012 · Genes & Development
Regulation of Steatohepatitis and PPARγ Signaling by Distinct AP-1 Dimers
Sebastian C. Hasenfuss, Latifa Bakiri, Martin Kristian Thomsen, Evan G. Williams, Johan H. Auwerx, Erwin Friedrich Wagner · 2014 · Cell Metabolism
Hepatic steatosis exacerbated by endoplasmic reticulum stress-mediated downregulation of FXR in aging mice
Xuelian Xiong, Xiaolin Wang, Yan Lu, E. Wang, Zhijian Zhang, Jian Yang, Huijie Zhang, Xiaoying Li · 2013 · Journal of Hepatology
SREBP Regulation of Lipid Metabolism in Liver Disease, and Therapeutic Strategies
Na Li, Xiaodan Li, Yifu Ding, Xiao Liu, Karin Diggle, Tatiana Kisseleva, David A. Brenner · 2023 · Biomedicines
Mangiferin: An effective therapeutic agent against several disorders (Review)
Du, Suya, Liu, Huirong, Lei, Tiantian, Xie, Xiaofang, Wang, Hailian, He, Xia, Tong, Rongsheng, Wang, Yi · 2018 · Molecular Medicine Reports
Carboxylesterase 2 prevents liver steatosis by modulating lipolysis, endoplasmic reticulum stress, and lipogenesis and is regulated by hepatocyte nuclear factor 4 alpha in mice
Yuanyuan Li, Munaf Hashim Zalzala, Kavita S. Jadhav, Yang Xu, Takhar Kasumov, Liya Yin, Yanqiao Zhang · 2016 · Hepatology
Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells
Shanchun Guo, Mingli Liu, Guangdi Wang, Marta Torroella‐Kouri, Ruben Rene Gonzalez-Perez · 2012 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Current status, problems, and perspectives of non-alcoholic fatty liver disease research
Naoki Tanaka, Takefumi Kimura, Naoyuki Fujimori, Tadanobu Nagaya, Michiharu Komatsu, Eiji Tanaka · 2019 · World Journal of Gastroenterology
miRNA Signature in NAFLD: A Turning Point for a Non-Invasive Diagnosis
Paola Dongiovanni, Marica Meroni, Miriam Longo, Silvia Rossana Fargion, Anna Ludovica Fracanzani · 2018 · International Journal of Molecular Sciences
Bile acid receptors in non-alcoholic fatty liver disease
Yuanyuan Li, Kavita S. Jadhav, Yanqiao Zhang · 2013 · Biochemical Pharmacology
Dietary Anthocyanins as Nutritional Therapy for Nonalcoholic Fatty Liver Disease
Luca V. C. Valenti, Patrizia Riso, Alessandra Mazzocchi, Marisa Porrini, Silvia Rossana Fargion, Carlo Virginio Agostoni · 2013 · Oxidative Medicine and Cellular Longevity
NAFLD risk alleles in PNPLA3, TM6SF2, GCKR and LYPLAL1 show divergent metabolic effects
Eeva Sliz, Sylvain P Sebert, Peter Würtz, Antti J. Kangas, Pasi Soininen, Terho J. Lehtimäki, Mika A. P. Kähönen, Jorma S.A. Viikari, Minna Männikkö, Mika Ala‐Korpela et al. · 2018 · Human Molecular Genetics
Dissociating fatty liver and diabetes
Zheng Sun, Mitchell A. Lazar · 2012 · Trends in Endocrinology and Metabolism
Regulation of glucose and lipid homeostasis by adiponectin: Effects on hepatocytes, pancreatic β cells and adipocytes
Caroline Tao, Angelica J. Sifuentes, William L. Holland · 2013 · Best Practice & Research Clinical Endocrinology & Metabolism
Body mass index in childhood and adult risk of primary liver cancer
Tina Landsvig Berentzen, Michael Gamborg, Claus Holst, Thorkild I. A. Sørensen, Jennifer L. Baker · 2013 · Journal of Hepatology
Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and Targets of Therapies?
Agostino Di Ciaula, Salvatore Passarella, Harshitha Shanmugam, Marica Noviello, Leonilde Bonfrate, David Q.‐H. Wang, Piero Portincasa · 2021 · International Journal of Molecular Sciences
Kaempferol and Kaempferide Attenuate Oleic Acid-Induced Lipid Accumulation and Oxidative Stress in HepG2 Cells
Fangfang Tie, Jin Jia Ding, Na Hu, Qi Zheng Dong, Zhi Chen, Honglun Wang · 2021 · International Journal of Molecular Sciences